Research & Development
6 July 2022 - Biopharmaceutical company IVERIC bio Inc (Nasdaq: ISEE) and drug delivery technology provider DelSiTech Ltd revealed on Wednesday that they have signed an exclusive global licence agreem...
5 July 2022 - - The US Food and Drug Administration has lifted the clinical hold placed on the Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated pancreatic...
5 July 2022 - - US-based biopharmaceutical company Iveric bio, Inc. (NASDAQ: ISEE) and Finland-based technology specialist DelSiTech Ltd have inked an exclusive global license agreement providing...
5 July 2022 - - The US FDA has approved a content uniformity method using US-based Agilent Technologies Inc's (NYSE: A) TRS100 Raman quantitative pharmaceutical analysis system, the company said....
5 July 2022 - - US-based biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) has posted positive topline data from Part A of an ongoing Phase 2 clinical trial evaluating the po...
5 July 2022 - - The US Food and Drug Administration has informed US-based Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) that the Agency is planning to reconvene the Peripheral and Central Nervous System...
Related Headlines